MassMutual Private Wealth & Trust’s Zevra Therapeutics ZVRA Stock Holding History

MassMutual Private Wealth & Trust’s Portfolio ZVRA Stock Details ZVRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.38K	Hold	445	–	–	﹤0.01%	1592
2026 Q1	$4.15K	Hold	445	–	–	﹤0.01%	1753
2025 Q4	$3.99K	Sell	445 -20	-4%	-$189	﹤0.01%	1771
2025 Q3	$4.42K	Buy	465 +210	+82%	+$2.11K	﹤0.01%	1723
2025 Q2	$2.25K	Buy	255 +105	+70%	+$852	﹤0.01%	1917
2025 Q1	$1.12K	Buy	+150	New	+$1.19K	﹤0.01%	2093

Other funds holding ZVRA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

MassMutual Private Wealth & Trust's ZVRA Position: Q2 2026 in Review

MassMutual Private Wealth & Trust held its Zevra Therapeutics (ZVRA) position steady in Q2 2026 at 445 shares worth $6.38K. The position accounts for ﹤0.01% of the portfolio, ranked #1592.

MassMutual Private Wealth & Trust first reported a position in ZVRA in Q1 2025 and has held it in 6 quarters since. 157 funds tracked by Wall St. Rank hold ZVRA as of Q2 2026.

MassMutual Private Wealth & Trust held 445 shares of Zevra Therapeutics worth $6.38K as of Q2 2026.
MassMutual Private Wealth & Trust left its Zevra Therapeutics share count unchanged in Q2 2026.
Zevra Therapeutics made up ﹤0.01% of MassMutual Private Wealth & Trust's portfolio in Q2 2026, its #1592 holding.
MassMutual Private Wealth & Trust first reported a position in Zevra Therapeutics in Q1 2025 and has held it in 6 quarters since.
157 funds tracked by Wall St. Rank held Zevra Therapeutics as of Q2 2026.

Based on MassMutual Private Wealth & Trust's 13F filing for Q2 2026, filed 2 Jul 2026.